CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
Allogeneic Natural Killer T-Cells Expressing CD19 Specific Chimeric Antigen Receptor and Interleukin-15 in Relapsed or Refractory B-Cell Malignancies
Sponsor: Baylor College of Medicine
This PHASE1 trial investigates Refractory B-Cell Non-Hodgkin Lymphoma and Refractory B-Cell Small Lymphocytic Lymphoma and is currently ongoing. Baylor College of Medicine leads this study, which shows 19 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
19 versions recorded-
Aug 2025 — Present [monthly]
Active Not Recruiting PHASE1
-
Jul 2025 — Aug 2025 [monthly]
Active Not Recruiting PHASE1
-
Jun 2025 — Jul 2025 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Oct 2024 — Jun 2025 [monthly]
Recruiting PHASE1
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE1
▶ Show 14 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1
-
Jun 2023 — Jul 2024 [monthly]
Recruiting PHASE1
-
Mar 2023 — Jun 2023 [monthly]
Recruiting PHASE1
-
Sep 2022 — Mar 2023 [monthly]
Recruiting PHASE1
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE1
-
Feb 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Aug 2020 — Oct 2020 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE1
-
Feb 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE1
-
Dec 2019 — Feb 2020 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2019 — Dec 2019 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor College of Medicine
- Center for Cell and Gene Therapy, Baylor College of Medicine
- National Cancer Institute (NCI)
- The Methodist Hospital Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .